Pre-COVID world traveler, wannabe foodie, and cancer zapper @NorthwesternMed Radiation Oncology #radonc #hncsm #lcsm

Chicago, IL
Joined April 2018
Laila Gharzai MD LLM retweeted
On Saturday, May 30, Laila Gharzai, MD, LLM, (@LGharzai) and Devalingam Mahalingam, MD, PhD, (@DevaMahalingam) showcased their research during the Poster Session. Session Chair Priya U. Kumthekar, MD discussed #CentralNervousSystemTumor in her Oral Abstract Session. @ASCO
1
1
4
149
Laila Gharzai MD LLM retweeted
Great session at CHEST 2025 to discuss changes and implementation challenges of TNM-9 Staging of Lung Cancer. @accpchest @AAB_IP @wabipconnect @DukePulmFellows @DukeSurgery @DukeCancer @DukeCancerNTWK @DukePACC
4
2
857
Dr @LGharzai on medical debt in pts receiving #radiation. #ASTRO25 Most had OOP expenses (61.1%, n=8701), mean $825.80 (SD 2114.5), median $25 (IQR 0-685.90). Few had bad debt (2.7%, n=397), with a mean of $1109.90 outstanding (SD 4215.5) after a mean of 9.3 mo (SD 3.9).
2
2
11
701
Our team demonstrates the first ever validation of COST Item 12 as a single item screening measure for financial toxicity—can be used as a brief, single item screener with excellent sensitivity for detecting patients at high risk of financial distress. ascopubs.org/doi/10.1200/OP-…
1
136
Laila Gharzai MD LLM retweeted
Asking patients for guidance based on their lived experience is key, says Lurie Cancer Center's Laila Gharzai, MD, (@LGharzai), co-author of a recent study about #financialtoxicity screening preferences in @JCOOP_ASCO. "They've actually been through it."
Cancer patients want providers to talk to them about financial needs during treatment. bit.ly/3Arn0Dx
3
6
733
Poster #282 right now in the exhibit hall!
Underway at #ASCO24, Laila Gharzai, MD, @LGharzai, is discussing the impact of biomarker testing in metastatic non-small cell lung cancer during the Quality Care / Health Service Research Session. @NorthwesternMed
1
5
602
Laila Gharzai MD LLM retweeted
Surrogate endpoints for HPV+ HN cancer; an analysis of 5 NRG Oncology studies. LRPFS, DMFS, and PFS seem to fit the bill. authors.elsevier.com/c/1ifvZ… @LGharzai
1
7
24
1,988
Excited to share our work showing the first validation of surrogate endpoints in HPV+ oropharyngeal cancer! We show that LRPFS, DMFS, and PFS correlate with 5yr OS. Important for trial design in this evolving dx space @MierzwaMichelle @StatMatt9 @NRGonc sciencedirect.com/science/ar…
1
3
1
22
1,803
The FACT-HN-RAD offers a means to serially monitor patients with radiation therapy-related adverse effects and recovery over time in both the clinical and research settings. ja.ma/3sfS84e @lgharzai @mierzwamichelle
2
3
808
LCRF Together Chicago is June 6 at The Ivy Room! Join our gathering & educational event with Drs. Nisha Mohindra, Jessica Donington, Laila A. Gharzai, & Melanie M. Smith; and moderator Ivy Elkins. Refreshments 5:30 PM; panel 6:30 PM. RSVP: LCRF.org/togetherchicago. #LungCancer
3
1
5
1,366
Laila Gharzai MD LLM retweeted
Original Article: “Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer,” by @LGharzai et al. eviden.cc/3zeUxg1 #OncoAlert #MedTwitter

2
4
1,501
Laila Gharzai MD LLM retweeted
Read our April 15 issue! 📗 acsjournals.onlinelibrary.wi… ✔️ Top advances in hepatobiliary cancer by @TimGreten & Coffman-D’Annibale ✔️ @BevGreen6 on DIP & nonadherence to health-protective behaviors ✔️ @lgharzai @reshmajagsi on financial toxicity & clinical trial design
1
4
7
1,768
Laila Gharzai MD LLM retweeted
We are ✨ECSTATIC✨ to have you all join us TOMORROW for Northwestern's 5th annual Women in Medicine conference! While online registration is closed, onsite registration will be available during the conference! 🎉Looking forward to seeing you all🎉
1
13
2
19
5,464
Laila Gharzai MD LLM retweeted
Financial impact of therapies should be measured. Patients who are informed of therapy implications—efficacy, side effects, cost, & financial impact—are able to select the best cancer treatment for themselves. acsjournals.onlinelibrary.wi… @lgharzai @reshmajagsi CC: @VivekSubbiah
1
7
21
4,166